Tyratech (DI) Share Discussion Threads

[al h] 22/8/2016 12:41

LOL, bizarre prices ... all over the place. Whoever's paying 3.25 needs to find a new broker, or are these just more bogus trades ?

[michaelsadvfn] 22/8/2016 12:04

I added a few today at 3.085. Too cheap to ignore imo.

674k bought vs 178k sold so far today. Not wishing to tempt fate but this has to be as cheap as it's going to get.

[nobbygnome] 22/8/2016 12:01

Vamousse and Guardian sales in France should also contribute in the second half. The company is now valued at just about 1 times turnover for this year which is ridiculous. You would expect that sort of valuation for a company with stagnant turnover not a company like TYR where turnover is increasing rapidly with more to come. Of course fund raisings can be another drag on a valuation but TYR really shouldn't need more funds if the loss this year is as expected, which was stated in the trading update. I guess it can never be ruled out completely but I doubt that is going to happen.

I am toying with getting a few more.....

Nobby

[michaelsadvfn] 22/8/2016 11:51

A valid point but they would have also advertised heavily last year during the back-to-school period but it didn't stop Vamousse increasing market share to 7%.

Vamousse

Unit sales of Vamousse were in line with expectations, showing strong growth over the corresponding period for 2015 across all geographies and customers. Vamousse continues to establish itself as a leading brand and is performing well in the market against competitor products, gaining market share.

1H/2016? I'm going to have a stab at $4.5m product sales, up from $3.3m(1H/2015).
From here on in we can also reckon on MWI contributing with sales of PureScience.

[mudbath] 22/8/2016 11:17

Hedrin and Lyclear are being heavily advertised across many TV channels which,temporarily,might prove detrimental to TYRU product sales.

[michaelsadvfn] 22/8/2016 10:13

The 'bent spiv scum' are simply entertaining our seller. Anyone selling 166k @ 2.8p is either a novice or a desperado. Maybe both.

[al h] 22/8/2016 09:53

I'm guessing the 2 x 100Ks weren't sells, buys in fact at that price or a rollover. Doesn't stop the monkey scum marking down regardless ... but only the bid predictably. Bent spiv scum that drag the "square mile" into the gutter on a daily basis.

[ferris_bueller] 22/8/2016 09:34

Morning,

100k for me @ 3.075

Can't buy any more for a couple of weeks, but will still be watching with interest.

GLA
ferris

[michaelsadvfn] 19/8/2016 17:07

3.10....even better.

[michaelsadvfn] 19/8/2016 12:57

The mm's haven't taken any stock on board at under 3p so you have zero chance of getting your order filled.

They operate on 2-3% margins. If you stick an order in at 3.15 I'm sure they'd oblige.

[ferris_bueller] 19/8/2016 12:50

Well, my 100k buy @3p has been rejected everyday this week.
Maybe it will get filled today?


GLA
ferris

[michaelsadvfn] 19/8/2016 10:14

Some sort of plank I'll give you that, he/she could have started dumping at 4p instead of waiting until the bid hit 3p.

[al h] 19/8/2016 10:08

It's a shorter, probably HarrythePlank

[michaelsadvfn] 19/8/2016 09:49

2.75 on the bid coming up if this 100k seller continues to dump stock...

[michaelsadvfn] 16/8/2016 13:26

A wonderful contribution to the thread David.

Did you ever receive Soupdragon's share certificate?

Just asking like.

[michaelsadvfn] 16/8/2016 12:52

Selling at 3p per share, it looks like a few punters have lost patience.

Emotions taking over from logic.

[mudbath] 13/8/2016 11:18

Thanks Ferris_Bueller and LR2.
Interesting info.
I wonder how we could advance onto the NHS list in England,where Hedrin is currently available via prescription.

[ferris_bueller] 13/8/2016 09:05

LR2
thanks for that.
It is a very interesting read.

Also worth highlighting this part:-

Pharmacies should be mindful of the school calendar when preparing their product offering.

“You always get a spike of headlice sales in September when the kids start going back to school,” says Mr Baki. This month presents the sector with its most significant chance to capitalise on a renewed interest in potential treatments.

Although headlice can be a perennial problem, Ms Feltham agrees that pharmacists should be aware of the “seasonality” in the headlice market, which centres around three key dates.

“We see increases in shoppers and spend around back-to-school times – [in] September, post-Christmas and post-Easter. Pharmacists should capitalise on these times, by driving awareness of treatments and offering advice.”

+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++



Obviously there will be a delayed reporting effect on sales, but definitely worth noting!

Furthermore, the fact that TyraTech Vamousse is not currently the UK market leader, it is however the only product mentioned in the article as being available FREE of Charge (FoC)on the NHS for those qualifying for the Minor Ailments Service (MAS) in Scotland.

With the onset of the head lice season (September), this should create plenty of potential for Vamousse to eat into the UK market share of others (Hedrin, Full Marks and Lyclear) which combined currently account for 75% of the UK market.

I do expect however, that it will only be available through MAS FoC as a remedy and not as a preventative.

NHS/MAS/Scottish Government link:-




Also worth noting that as well as local pharmacists, MAS Scotland is dispensed through branches of BOOTS, which lends itself for corporate feedback on which products to stock and sell throughout the rest of their UK branches?



GLA

[lr2] 12/8/2016 22:15

...While this is bad news for families with young children, it is good news for the community pharmacy sector, as headlice treatments are enjoying a boost in sales. According to Kantar Worldpanel, the total market in the UK for headlice products in 2016 is £18.7 million, up 55% on last year. Of those sales, pharmacies account for 45%, with supermarkets making up 51%.

...Pharmacy can look forward to even greater growth in the headlice category in future, Mr Wicks predicts. “There is, undoubtedly, a threat from the [supermarkets] – as in so many over-the-counter categories. But NHS-approved treatments, such as Vamousse [manufactured by TyraTech], which is included within the minor ailments service in Scotland, [will] help to maintain pharmacy’s positioning as the first port of call for these products.”

[michaelsadvfn] 12/8/2016 12:06

Well done mate. Good price for anyone who can look further out than this week.

Nice to see the sells being mopped up.

[ferris_bueller] 12/8/2016 12:03

another 100k for me filled @ 3.5

exciting times
GLA

[mudbath] 12/8/2016 11:11

Same with TYR michaelsadvfn,where one can sell 100k at a premium and where all the recent sales were mopped up in one 900K hit for £22k.

[michaelsadvfn] 12/8/2016 10:26

First time in a while that I can get a quote to sell 100k. 3.35p offered.

My, things are looking up. lol